Natco Pharma consolidated net profit declines 67.84% in the September 2021 quarter
Sales decline 52.98% to Rs 377.20 crore
Net profit of Natco Pharma declined 67.84% to Rs 65.10 crore in the quarter ended September 2021 as against Rs 202.40 crore during the previous quarter ended September 2020. Sales declined 52.98% to Rs 377.20 crore in the quarter ended September 2021 as against Rs 802.20 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales377.20802.20 -53 OPM %18.6934.46 -PBDT104.50299.40 -65 PBT69.80270.70 -74 NP65.10202.40 -68Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 11 2021 | 3:55 PM IST